RecruitingNCT06913998
The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
Sponsor
National Taiwan University Hospital
Enrollment
65 participants
Start Date
Dec 27, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.
Eligibility
Min Age: 1 YearMax Age: 25 Years
Inclusion Criteria1
- Participants who are diagnosed with inflammatory bowel disease.
Exclusion Criteria1
- Participants who refused to have blood test for NUDT15 gene evaluation.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06913998
Related Trials
FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
NCT062867095 locations
Predictors of Prognosis in IBD Patients
NCT056530111 location
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395175 locations
IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms
NCT060946081 location
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
NCT063151791 location